US 11236099
Heterocyclic compound
granted A61KA61K31/4355A61K31/444
Quick answer
US patent 11236099 (Heterocyclic compound) held by Takeda Pharmaceutical Company Limited expires Mon Jan 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Feb 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K31/4355, A61K31/444, A61K31/501, A61K31/506